Bluejay Diagnostics, Inc. Unrealized Gain (Loss) on Derivatives
Bluejay Diagnostics, Inc. (BJDX) reported Unrealized Gain (Loss) on Derivatives of $9.68 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2022-05-09
- Bluejay Diagnostics, Inc. unrealized gain (loss) on derivatives for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Bluejay Diagnostics, Inc. unrealized gain (loss) on derivatives for the quarter ending 2021-03-31 was $6.11K.
- Bluejay Diagnostics, Inc. unrealized gain (loss) on derivatives for the quarter ending 2020-12-31 was $2.89K.
- Bluejay Diagnostics, Inc. unrealized gain (loss) on derivatives for the quarter ending 2020-09-30 was $4.34K.
- Bluejay Diagnostics, Inc. unrealized gain (loss) on derivatives for fiscal 2021 was $9.68K.
- Bluejay Diagnostics, Inc. unrealized gain (loss) on derivatives for fiscal 2020 was -$42.43K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $9.68K 10-K · filed 2022-03-10 | ||
| 2021-09-30 | $9.68K 10-Q · filed 2021-12-16 | |||
| 2021-03-31 | $6.11K 10-Q · filed 2022-05-09 | $9.00K derived: sum of 2 quarters · filed 2022-05-09 | $13.34K derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $2.89K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $7.23K derived: sum of 2 quarters · filed 2022-03-10 | -$42.43K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $4.34K 10-Q · filed 2021-12-16 | -$45.32K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |